Enorama Pharma AB (publ) (STO: ERMA)

Enorama Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	247	114	28	171	195	224
Market Cap Growth	165.79%	308.04%	-83.60%	-12.51%	-12.75%	-28.09%
Enterprise Value	238	108	27	171	197	216
Last Close Price	4.09	2.51	2.95	17.98	26.75	32.73
PS Ratio	20.52	84.29	4.10	13.36	43.74	21.47
PB Ratio	8.07	5.86	0.89	8.01	110.00	31.21
P/TBV Ratio	8.07	5.86	0.89	8.01	110.00	31.21
EV/Sales Ratio	17.95	79.67	3.88	13.39	44.18	20.71
Debt / Equity Ratio	0.01	0.02	0.06	0.18	3.21	-
Asset Turnover	0.34	0.03	0.14	0.28	0.11	0.26
Inventory Turnover	1.38	1.48	3.66	6.03	-	-
Quick Ratio	1.62	0.80	0.68	1.77	0.59	1.59
Current Ratio	2.90	1.27	0.95	1.92	0.69	1.73
Return on Equity (ROE)	-133.12%	-174.74%	-158.97%	-239.87%	-523.81%	-196.70%
Return on Assets (ROA)	-50.29%	-62.91%	-52.64%	-37.20%	-34.45%	-35.12%
Return on Capital (ROIC)	-73.12%	-97.89%	-89.55%	-104.69%	-196.14%	-111.06%
Earnings Yield	-13.06%	-38.97%	-149.82%	-16.22%	-12.00%	-10.62%
FCF Yield	-17.11%	-36.12%	-117.48%	-17.67%	-12.54%	-12.46%
Buyback Yield / Dilution	-253.96%	-26.23%	-11.44%	-3.47%	-1.47%
Total Shareholder Return	-253.96%	-26.23%	-11.44%	-3.47%	-1.47%

Source: S&P Capital IQ. Standard template. Financial Sources.